Connect with us
European Gaming Congress 2024

Artificial Intelligence

Lab Automation Market to Reach $11.31 Billion by 2031, Driven by Rising Pharmaceutical & Biotech R&D Expenditures and Increasing Demand for Automated Laboratories and Instruments – Report by Meticulous Research®

Published

on

lab-automation-market-to-reach-$11.31-billion-by-2031,-driven-by-rising-pharmaceutical-&-biotech-r&d-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments-–-report-by-meticulous-research

REDDING, Calif., Sept. 16, 2024 /PRNewswire/ — According to a new market research report titled, ‘Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics),End User—Global Forecast to 2031.

The lab automation market is projected to reach $11.31 billion by 2031, at a CAGR of 7.3% from 2024 to 2031.
Download FREE PDF Brochure Of Lab Automation Market – https://www.meticulousresearch.com/pressrelease/967/lab-automation-market-2031
Rising pharmaceutical and biotech R&D expenditures, the increasing demand for automated laboratories and instruments, the high prevalence of chronic and infectious diseases, and initiatives supporting life sciences R&D are driving the growth of the lab automation market. However, the high costs of advanced lab automation equipment and funding & infrastructure limitations in developing countries are factors restraining the growth of this market.
Furthermore, growth in genomics & proteomics research, the increasing focus on food safety & quality, rising awareness & growing adoption of personalized medicines, and emerging economies are expected to generate growth opportunities for the players operating in the lab automation market. However, equipment maintenance & repair and data security & privacy concerns are major challenges impacting market growth.
Get Insightful Data On Regions, Market Segments, Customer Landscape, And Top Companies (Charts, Tables, Figures And More) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Automated Laboratories: Effective Management of Clinical Workflows
Lab automation is being widely adopted in clinical laboratories to increase accuracy and efficiency and reduce costs and errors. In the field of medicine, a diagnostic error can incur very high costs. Hence, automating clinical laboratories can significantly reduce human errors and associated costs.
Automating clinical laboratories can have a positive impact on patient outcomes. Quick and reliable diagnostic results allow medical professionals to initiate appropriate treatments, improving the chances of patient survival. Additionally, limited resources, long waiting times for diagnostic results, and the shortage of skilled laboratory staff can lead to poor patient outcomes. The implementation of lab automation in clinical laboratories helps mitigate these issues and provides quick and reliable results, improving patient outcomes.
In the U.S., an estimated 10–20% of diagnoses are inaccurate and result in 40,000–80,000 deaths each year. Automation improves the ordering, testing, and reporting of diagnostic tests and ensures higher throughput, increased productivity, efficient use of reagents & materials, and standardization, decreasing errors and improving turnaround times.
Browse In-depth Report Now – https://www.meticulousresearch.com/product/lab-automation-market-1221
The players operating in this market are focused on launching new automated diagnostic instruments. For instance:
In May 2024, Abbott Laboratories (U.S.) launched its GLP Systems Track in India to support the high-volume needs of laboratories.In September 2023, Yourgene Health plc (U.K.) launched the Yourgene MagBench Automated DNA Extraction Instrument and Kit for Noninvasive Prenatal Testing (NIPT) workflows.In June 2023, Becton, Dickinson and Company (U.S.) launched its BD FACSDuet Premium Sample Preparation System for cellular diagnostic applications.In January 2023, QIAGEN N.V. (Netherlands) launched the EZ2 Connect MDx Platform for automated sample processing in diagnostic labs.In May 2022, Becton, Dickinson and Company (U.S.) launched BD COR MX, a fully automated, high-throughput infectious disease molecular diagnostics platform.Lab Automation Market Analysis: Key Segmental Findings
By Product: In 2024, the systems segment is expected to account for the major share of 71.5% of the lab automation market. However, the software segment is expected to grow at the fastest CAGR of 7.4% during the forecast period of 2024–2031.By Application: In 2024, the drug discovery segment is expected to account for the largest share of the market. However, the clinical diagnostics segment is expected to grow at the fastest CAGR during the forecast period of 2024–2031.By End User: In 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of 41.0% of the global market.Explore the Key Market Segments Driving Growth (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Geographic Analysis:
North America Dominates the Global Market
North America is expected to account for the largest share of 40.8% of the lab automation market. In terms of value, in 2024, the U.S. is expected to account for the major share of 92% of the lab automation market in North America. Pharmaceutical companies in the U.S. are at the forefront of adopting cutting-edge technologies, with a strong emphasis on the implementation of lab automation systems to enhance operational efficiency and gain a competitive edge in the pharmaceutical sector. The adoption of lab automation technologies is driven by several factors, including the surging need for high-throughput analysis, increasing investments in research and development, laboratories’ growing need for increased efficiency, precision, and productivity, and the increasing focus on genomics research and genetic testing. These dynamics are boosting the adoption of lab automation across the country. The U.S. has low market barriers for developing and commercializing pharmaceuticals due to the supportive domestic environment. With the availability of government funding for research activities, robust capital markets, and strong academic research in the country, the U.S. is the world’s largest scientific research base, attracting most global venture capital investments in the biotechnology industry.
Asia-Pacific to Witness Rapid Growth
Asia-Pacific is expected to record the fastest growth over the forecast period, with the regional market reaching $2.74 billion by 2031. The high growth of this regional market is driven by the expanding pharmaceutical & biotechnology industries, rapidly improving healthcare infrastructure, growth in pharmaceutical research, and increasing government funding in APAC. The Asia-Pacific region has become one of the most attractive markets for healthcare & life sciences companies worldwide, primarily due to changing demographics and accelerated economic growth in the region. Countries such as China, India, South Korea, and Indonesia are expanding their healthcare infrastructure, driving the demand for laboratory automation.
Have specific research needs? Request a customized research report – https://www.meticulousresearch.com/request-customization/cp_id=1221
In 2024, China is expected to account for the largest share of the lab automation market in Asia-Pacific. The country’s large market share is mainly attributed to government initiatives focusing on research and development, increasing R&D expenditures of pharmaceutical and biopharmaceutical companies, favorable regulatory policies, the rising prevalence of infectious & chronic diseases, the rising geriatric population, and the increased demand for lab automation among clinical laboratories due to increased disease prevalence.
Germany Continues to Dominate the Lab Automation Market in Europe
In 2024, Germany is expected to account for the largest share of the lab automation market in Europe. Factors such as increasing government investments in the pharmaceutical industry, growing biotech & pharmaceutical R&D expenditures, rising healthcare spending, increasing sample volumes in laboratories due to the rising incidence of chronic and infectious diseases, the increased demand for precision medicines, and the rising focus on genomics research contribute to the country’s largest market share. Germany has a favorable environment for developing and producing research-intensive, high-grade products. According to German Trade & Invest, in 2021, the pharmaceutical industry in Germany invested over $9.1 billion (€7.7 billion) in research and development. Additionally, the government and funding organizations have pledged to substantially increase public & private R&D spending and researchers by 2030 as part of the country’s Sustainable Development Goals (SDG). Thus, increasing government funding for research, the wide availability of technologically advanced laboratory informatics solutions, and laboratories’ need to reduce errors, and associated costs are expected to drive the growth of the lab automation market in Germany.
Need Insights on Regional Data? Check Out Our Detailed Analysis (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Market: Competition Analysis
This report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted over the past 3–4 years. Major companies in the lab automation market have implemented various strategies to expand their product offerings and global footprints and augment their market shares. The key strategies followed by most companies in the lab automation market include product launches, product enhancements, approvals, partnerships, collaborations, agreements, acquisitions, and expansions. The key players operating in the lab automation market include Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Learn About the Top Companies Influencing Market Dynamics (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Industry Overview: Latest Developments from Key Industry Players
In July 2024, INPECO SA (Switzerland) launched FlexLab X, a next-generation total lab automation system (TLA), at the Annual Scientific Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM 2024). This system can combine analyzers from different vendors, enable space-saving layouts, offers a sleek graphical user interface, and streamlines workflows.In February 2024, Carbon, Inc. (U.S.) launched its Automatic Operation (AO) suite of solutions designed to meet the needs of dental labs, setting new standards in lab automation.In September 2023, Bio-Rad Laboratories, Inc. launched the PTC Tempo 48/48 and PTC Tempo 384 thermal cyclers that are designed to aid PCR applications such as sequencing, cloning, and genotyping.In August 2023, F. Hoffmann-La Roche Ltd launched the Cobas Connection Modules (CCM) sample conveyor systems to enable flexibility in laboratory designs.In July 2023, Agilent Technologies, Inc. launched the BioTek Gen6 Software, which is used for all BioTek detection instruments. This software also provides an intuitive user interface that offers complete control of BioTek microplate readers for absorbance, fluorescence, and luminescence measurements for endpoint and kinetic assays.In July 2023, Thermo Fisher Scientific, Inc. launched the Diomni Enterprise Software, which provides a digital platform to support testing workflows in order to accommodate rapidly evolving needs.In July 2023, Bio-Rad Laboratories launched the IH-500TM NEXT System, a fully automated system for use with Bio-Rad’s ID Cards for routine testing and specialized testing such as newborn screening.In February 2023, Revvity, Inc. launched the EnVision Nexus Multimode Microplate Reader, which provides high-throughput screening and accelerates drug discovery results.In February 2023, Beckman Coulter Life Sciences collaborated with Sciex (U.S.) to provide comprehensive workflows for high-throughput screening HT-ADME and synthetic biology studies. The Echo MS System, which is based on Sciex’s Acoustic Ejection Mass Spectrometry technology, is now compatible with Beckman’s Echo Liquid Handlers.In February 2023, Tecan Group Ltd. collaborated with Element Biosciences, Inc. (U.S.) to offer a true benchtop NGS workflow with the MagicPrep NGS and AVITI System. This collaboration was aimed at enabling the direct conversion of NGS libraries without affecting sample quality.In June 2022, Beckman Coulter Life Sciences launched the Biomek NGeniuS liquid handling system to automate the labor-intensive process of manual library construction and reagent transfers. The system also eliminates loading errors.In April 2022, Revvity, Inc. collaborated with Scitara Corporation (U.S.) to integrate PerkinElmer’s Signals Research Suite informatics platform and Scitara’s iPaaS universal connectivity solution to facilitate fully connected laboratories along with standard data integrity, data mobility, system flexibility, and user reconfigurability.The report provides a competitive dashboard summarizing the market positioning of the 20 profiled market players in four quadrants, namely Industry Leaders, Differentiators, Emerging Companies, and Vanguards. These companies are positioned based on various parameters, including revenue, depth of offerings, brand equity, geographic presence, innovation, and organic & inorganic growth strategies. Thermo Fisher Scientific, Inc. (U.S), Danaher Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Hamilton Company (U.S.), Abbott Laboratories (U.S.), and Siemens Healthineers AG (Germany) are positioned in the industry leaders quadrant.
IMMEDIATE DELIVERY AVAILABLE | BUY THIS RESEARCH REPORT (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/Checkout/13937383
Scope of the Report:
Lab Automation Market Assessment–by Product
SystemsAutomated Liquid Handling SystemsAutomated Nucleic Acid Purification SystemsAutomated ELISA SystemsAutomated Microplate ReadersAutomated Storage & Retrieval SystemsOther Lab Automation SystemsSoftwareLaboratory Information Management Systems (LIMS)Electronic Lab Notebook (ELN)Workstation/Equipment Automation SoftwareScientific Data Management Systems (SDMS)Lab Automation Market Assessment–by Application
Drug DiscoveryClinical DiagnosticsGenomics & Proteomics ResearchOther Applications(Note: Other applications include bioprocessing in biotechnology, cell analysis, basic research, forensic analysis, and quality control in the F&B industry.)
Lab Automation Market Assessment–by End User
Pharmaceutical & Biotechnology CompaniesHospitals & Diagnostic LaboratoriesAcademic & Research InstitutesOther End Users(Note: Other end users include the food & agriculture industries, forensic laboratories, blood banks, and environmental & quality testing laboratories.)
Lab Automation Market Assessment–by Geography
North AmericaU.S.CanadaEuropeGermanyU.K.FranceItalySpainRest of Europe (RoE)Asia-Pacific (APAC)ChinaJapanIndiaRest of APAC (RoAPAC)Latin AmericaMiddle East & AfricaBrowse More Related Reports:
Lab Automation Market is projected to hit $11.31 billion by 2031, growing at CAGR of 7.3% from 2024. Discover trends and growth factors driving this sector. – https://www.meticulousresearch.com/product/lab-automation-market-1221
Clinical Lab Automation Market is expected to reach $4.01 billion by 2031, at a CAGR of 7.8% from 2024 to 2031. – https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762
Electronic Lab Notebook Market is expected to grow at a CAGR of 7.1% to reach $787.7 million by 2029. – https://www.meticulousresearch.com/product/electronic-lab-notebook-eln-market-4341
NGS Automation Market is expected to grow at a CAGR of 13.4% from 2022–2029 to reach $1.33 billion by 2029. – https://www.meticulousresearch.com/product/ngs-automation-market-5271
Explore future of  Industrial Automation Software Market, projected to hit $59.5 billion by 2029.  – https://www.meticulousresearch.com/product/industrial-automation-software-market-5279
Pharmaceutical Automation Market, valued at $11.16 Bn in 2023, is projected to reach $25.11 Bn by 2031, growing at a 10.8% CAGR from $12.21 Bn in 2024. – https://www.meticulousresearch.com/product/pharmaceutical-automation-market-5280
Lab-grown Meat Market is projected to reach $1.99 billion by 2035, at a CAGR of 21.4% during  forecast period of 2025–2035. – https://www.meticulousresearch.com/product/lab-grown-meat-market-5293
North America Electronic Lab Notebooks Market is projected to reach $372.7 million by 2030, at a CAGR of 6.8% from 2024 to 2030. – https://www.meticulousresearch.com/product/north-america-electronic-lab-notebook-market-5604
Europe Electronic Lab Notebook (ELN) Market is projected to reach $264.3 million by 2030, at a CAGR of 7% from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-electronic-lab-notebook-market-5683
Pharmacy Automation Market is expected to reach $7.87 billion by 2030, at a CAGR of 7.6% during forecast period 2024–2030. – https://www.meticulousresearch.com/product/pharmacy-automation-market-5700
Life science equipment market is projected to reach $97.96 billion by 2031, at a CAGR of 6.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/life-science-equipment-market-3937
Europe NGS automation Market to be worth $380.4 million by 2030, growing at a 13.4% CAGR from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-ngs-automation-market-5644
North America NGS Automation Market is expected to reach $776.1 million by 2030, at a CAGR of 14% during  forecast period 2024–2030 – https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736
Asia-Pacific NGS Automation Market is expected to reach $371 million by 2031 at a CAGR of 16.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/asia-pacific-ngs-automation-market-5790
Lab Automation Market Research Summary
Particular
Details
Page No
244
Format
PDF
Forecast Period
2024-2031
Base Year
2023
CAGR
7.30 %
Market Size (Value)
$11.31 billion
Market Size (Volume)
NA
Countries Covered
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa.
Key Companies
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.)
Click here to: Get Free Sample Pages of this Report
Hot Industry Reports: Emerging Trends and Market Forecasts
Veterinary Practice Management Software Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/veterinary-practice-management-software-market-1432
Asia Pacific Orthodontics Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-orthodontics-market-4978
Feed Software Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/feed-software-market-2639
Point-of-care Diagnostics Market Size & Trends Analysis 2030 – https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
Soluble Dietary Fibers Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/soluble-dietary-fibers-market-3953
Genomics Market: Size, Trends & Global Forecast to 2031 – https://www.meticulousresearch.com/product/genomics-market-1262
Healthcare Gamification Market Size, Share, & Growth 2030 – https://www.meticulousresearch.com/product/healthcare-gamification-market-2592
3D Cell Culture Market Size & Growth Insights 2024-2030 – https://www.meticulousresearch.com/product/3d-cell-culture-market-1246
South East Asia Collagen Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/south-east-asia-collagen-market-3634
Next Generation Sequencing Informatics (NGS) Market Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/ngs-informatics-market-3483
Recombinant Coagulation Factors Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/recombinant-coagulation-factors-market-1254
Crop Protection Chemicals Market Size, Share, Report, & Trends 2031 – https://www.meticulousresearch.com/product/crop-protection-chemicals-market-2584
Integrated Pest Management (IPM) Pheromones Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/integrated-pest-management-pheromones-market-5211
Sports Medicine Market: Size, Share, Forecast & Trends – https://www.meticulousresearch.com/product/sports-medicine-market-1215
MRI Infrastructure Capacity Assessment by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/mri-infrastructure-capacity-assessment-1217
Digital X-ray Systems Market Size, Share, Forecast, & Trends – https://www.meticulousresearch.com/product/digital-x-ray-systems-market-1183
Sports Technology Market Size, Trends & Forecast to 2030 – https://www.meticulousresearch.com/product/sports-technology-market-5584
Home Healthcare Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/home-healthcare-market-1280
Next Generation Sequencing Market Size, Share & Trends 2023-2030 – https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040
Cloud Analytics Market Insights: Size, Share & Trends – https://www.meticulousresearch.com/product/cloud-analytics-market-5208
Home Medical Equipment Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/home-medical-equipment-market-1284
IoT in Healthcare Market Size, Share, & Trends 2031 – https://www.meticulousresearch.com/product/iot-in-healthcare-market-4945
Surgical Sutures Market by Size, Share, & Trends 2030 – https://www.meticulousresearch.com/product/surgical-sutures-market-4947
Lab Automation Market: Share, Trends & Forecast Analysis – https://www.meticulousresearch.com/product/lab-automation-market-1221
Asia Pacific EV Battery Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-ev-battery-market-5217
Medical Imaging Market: Products, Applications, & Forecasts – https://www.meticulousresearch.com/product/medical-imaging-market-4950
Medical Ceramics Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/medical-ceramics-market-5538
Pharmaceutical Packaging Market Size, & Trends 2031 – https://www.meticulousresearch.com/product/pharmaceutical-packaging-market-5298
Ultrasound Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/ultrasound-market-4972
Tissue Diagnostics Market Insights: Size, Trends & Forecast – https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971
Contact:Mr. Khushal BombeMeticulous Market Research Inc.1267 Willis St, Ste 200 Redding,California, 96001, U.S.USA: +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- [email protected] Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Meticulousblog.org | Top Market Research Reports Blog – https://meticulousblog.org/Content Source: https://www.meticulousresearch.com/pressrelease/967/lab-automation-market
Photo: https://mma.prnewswire.com/media/2506511/Lab_Automation_Market.jpgLogo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/lab-automation-market-to-reach-11-31-billion-by-2031–driven-by-rising-pharmaceutical–biotech-rd-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments—report-by-meticulous-research-302249256.html

Continue Reading
Advertisement

Artificial Intelligence

NordVPN: Website categories employers don’t want you to visit

Published

on

nordvpn:-website-categories-employers-don’t-want-you-to-visit

Cybersecurity experts say that blocking certain websites lowers the risk of cyberattacks and removes distractions
LONDON, Sept. 18, 2024 /PRNewswire/ — According to data collected by a network security NordLayer, developed by the leading cybersecurity company NordVPN, a significant portion of employers (72%) block malicious and adult websites. Malicious websites can pose severe security threats by spreading malware, while adult websites are often restricted due to concerns over inappropriate content and productivity loss. Gambling sites are blocked by 43% of employers, likely due to concerns over addiction and productivity loss.

“In today’s threat landscape, where cyberattacks are becoming increasingly sophisticated, DNS filtering plays a pivotal role in safeguarding sensitive data, maintaining regulatory compliance, and preserving the integrity of organizational networks,” says Ugne Mikalajunaite, Country Manager Taiwan at NordVPN.
Employers seek to maintain a professional work environment
Besides just blocking adult websites, many managers take a step further to maintain a professional work environment. For example, 30% block dating sites, 28% do not allow access to sex education websites, and about 12% of employers even block lingerie sites.
Information or sales related to drugs websites are blocked by 37% of IT managers. Interestingly, 21% of employers block VPN websites, likely to prevent employees from circumventing network restrictions and accessing blocked content, which could pose security risks or productivity concerns.
Employer restriction priorities in different regions 
In Europe, businesses exhibit the greatest inclination to block adult content websites, with 67% of employers imposing such restrictions.
North America prioritizes mitigating security risks by having the highest percentage (70%) of employers blocking access to malware websites. Asia stands out with a distinct emphasis on curbing access to illegal or unethical content, as evidenced by 73% of employers restricting websites within this category.
Intriguingly, Asian businesses demonstrate a stricter approach towards gambling and gaming websites compared to their European and North American counterparts. While 64% of Asian employers block gambling sites, the figures stand at 37% and 38% for Europe and North America, respectively. Similarly, 36% of Asian organizations restrict access to gaming websites, contrasting with considerably lower rates of 9% in Europe and 20% in North America.
Another noteworthy regional disparity lies in the treatment of dating websites. European and North American employers exhibit relatively comparable stances, with 25% and 28% blocking this category, respectively. However, Asian businesses adopt a more restrictive policy, with 45% of employers denying access to dating sites.

View original content:https://www.prnewswire.co.uk/news-releases/nordvpn-website-categories-employers-dont-want-you-to-visit-302251846.html

Continue Reading

Artificial Intelligence

Apt.Residential Selects Yardi’s Technology to Support BTR Projects

Published

on

apt.residential-selects-yardi’s-technology-to-support-btr-projects

Australian property developer and operator to utilise innovative cloud platform for construction and investment accounting
SYDNEY, Sept. 18, 2024 /PRNewswire/ — Apt.Residential, an owner, developer and operator of residential properties in Australia, has chosen Yardi’s single connected platform to support growth, connect teams and manage capex projects and build.

With Yardi®, Apt.Residential can manage its funds and simplify complex financial processes, mitigate risk and deliver real-time insights into projects. The platform provides more visibility from investor to asset and delivers enhanced and accurate reporting. The company can access live data for costing, expenses, and revenue on all projects, from ground-up development to single-unit improvements and will allow Apt.Residential to grow the volume of units within BTR once they have operational units.
“We wanted to find the best platform for BTR that would support growth, streamline management of capex projects and handle our complex accounting,” said Michael Hogg, co-founder & head of operations for Apt.Residential. “Yardi’s single integrated platform was the best solution as it ensures our team can connect on one system and not worry about integrations or using multiple platforms.”
“We’re excited to work with Apt.Residential and support its growth as the company expands its BTR projects,” said Neal Gemassmer, vice president and general manager for Yardi. “Our connected platform will help Apt.Residential enhance communication and set them up so they’re ready to operate once development has completed.”
See how Yardi’s end-to-end technology can help drive your digitalisation strategies.
About Apt.ResidentialApt.Residential is a leading vertically integrated owner, developer, and operator of residential properties in Australia backed by global institutional capital. The company develops residential communities where wellbeing and connectedness come first. Its human-centric approach allows Apt.Residential to shape places for people who crave comfort, community, and elevated living. For more information, please visit aptresidential.au.
About Yardi
Celebrating its 40-year anniversary in 2024, Yardi® develops industry-leading software for all types and sizes of real estate companies across the world. With over 9,500 employees, Yardi is working with our clients to drive significant innovation in the real estate industry. For more information on how Yardi is Energised for Tomorrow, visit yardi.com.au.
Photo – https://mma.prnewswire.com/media/2508843/Yardi_AptResidential.jpgLogo – https://mma.prnewswire.com/media/737275/Yardi_Logo.jpg
 
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/aptresidential-selects-yardis-technology-to-support-btr-projects-302252015.html

Continue Reading

Artificial Intelligence

EQT to sell Open Systems, a Swiss leader in network and cyber security solutions, to Swiss Post

Published

on

eqt-to-sell-open-systems,-a-swiss-leader-in-network-and-cyber-security-solutions,-to-swiss-post

EQT Private Equity, together with its co-shareholders, to sell Open Systems to Swiss PostUnder EQT’s ownership, Open Systems transformed from a founder-led managed security services provider to a leading integrated network and cyber security companySince EQT’s acquisition in 2017, Open Systems has almost doubled its revenues and more than tripled its EBITDA, while significantly expanding its product offering to support customers on their network transformation and cybersecurity journeySTOCKHOLM, Sept. 18, 2024 /PRNewswire/ — EQT is pleased to announce that the EQT Mid Market Europe fund (“EQT”), together with its co-shareholders, have agreed to sell Open Systems (“Company”) to Swiss Post.

Headquartered in Zurich, Switzerland, Open Systems delivers network and cyber security capabilities in a single cloud-based platform known as Secure Access Service Edge (SASE). Open Systems’ innovative SASE Experience eliminates the complexity of secure global connectivity and network management, while providing seamless global 24×7 support. The Company plays a pivotal role in supporting customers globally in their network and cyber security transformation by offering a fully integrated, single-pane-of-glass cloud and software platform and supporting services.
EQT acquired a majority stake in Open Systems in 2017. During EQT’s ownership, the Company almost doubled its sales and more than tripled its EBITDA, while making substantial investments into its technology platform and transforming from a network-focused managed security services provider to a leading SASE player with extensive cyber security capabilities. Open Systems also built a Managed Extended Detection and Response (MXDR) division, which was carved out in 2023 and now operates as a standalone company under the brand Ontinue, which will be retained by EQT. Organic growth was complemented by three strategic add-on acquisitions, including Sqooba, a Swiss provider of data science, AI, cloud, and cyber services founded by the current Open Systems CEO Daniel Neuhaus.
As part of Swiss Post, Open Systems will continue its growth journey under the leadership of Daniel Neuhaus. With the acquisition, Swiss Post strengthens its role as provider of digital communication services by increasing its competences and know-how to support digitally connected businesses in Switzerland.
Daniel Neuhaus, CEO of Open Systems: “I would like to thank EQT for their support over the years and their hands-on involvement in our development. Swiss Post’s investment is a validation of our long-term strategy to become a leading SASE software provider with the best customer experience. With Swiss Post, we have found a sustainable partner in Switzerland who shares our values and will support us in continuously delivering best-in-class technology and services to our customers while continuing to drive innovation.”
Philipp Woerner, Director within EQT Private Equity’s Advisory Team: “We have been continuously impressed by Open Systems’ track record of technological innovation in the network and cyber security space. Thanks to the dedication and commitment of the management team led by Daniel, Open Systems delivers attractive technology and services from Switzerland to its customers globally. We could not have imagined a better future home for Open Systems than Swiss Post to support continuing the strong development.”
Nicole Burth, CEO of Swiss Post Communication Services, said: “Open Systems strongly complements our existing offerings in the area of cybersecurity. The Company is an excellent cultural fit and supports our strategy to bring cybersecurity to our Swiss customers. This makes the network and communication of businesses more efficient and secures it with the unique cloud security solutions Open Systems provides.”
The completion of this transaction is pending customary regulatory approvals and is anticipated to take place in Q4 2024.
ContactEQT Press Office, [email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-to-sell-open-systems–a-swiss-leader-in-network-and-cyber-security-solutions–to-swiss-post,c4039258
The following files are available for download:
https://mb.cision.com/Main/87/4039258/3007372.pdf
PR_EQT to sell Open Systems_18.09.24
https://news.cision.com/eqt/i/os-picture-1,c3334920
OS Picture 1

View original content:https://www.prnewswire.co.uk/news-releases/eqt-to-sell-open-systems-a-swiss-leader-in-network-and-cyber-security-solutions-to-swiss-post-302252201.html

Continue Reading

Trending